Ad-Tech Medical Joins ArchiMed
With offices in the US and Europe, ArchiMed is a leading investment firm focused exclusively on healthcare industries. Over the last twenty years, ArchiMed’s leadership team has directly managed and invested in over eighty small to large-size healthcare companies globally, representing over 50 billion of combined value.
ArchiMed invested in Ad-Tech Medical in 2020 ensuring the continued growth of the organization. Founded in 1983, Ad-Tech Medical has grown to become a world leader in the manufacturing of consumables, mainly electrodes, used in the fields of neurodiagnostic and neurosurgery.
Ad-Tech’s depth electrode design is considered to be the “gold standard” in the industry, where it has enjoyed significant historical growth in virtue of high product quality and reliability and has provided top-quality customer service for the neurosurgical market.
Ad-Tech has developed a global presence within a diversified customer base worldwide. The devices are registered and approved for use in over 60 countries, with the key markets being the US, Europe and Japan.
All of Ad-Tech’s products are manufactured in the United States with ISO 13485 certification.